- DESCRIPTION
- TABLE OF CONTENTS
- METHODOLOGY
- DOWNLOAD PDF
Europe Wound Care Market by Product [Dressings (Foam, Hydrocolloid, Collagen), Devices (NPWT, Debridement), Biological Skin Substitutes, Sutures, Staplers], Wound [Chronic, Acute], End User [Hospitals, Clinics, Home Care] -Forecast to 2031
USD 9.33 BN
MARKET SIZE, 2031
CAGR 6.0%
(2026-2031)
200
REPORT PAGES
150
MARKET TABLES
OVERVIEW
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The Europe Wound Care Market, valued at USD 6.62 billion in 2025, stood at USD 6.98 billion in 2026 and is projected to advance at a resilient CAGR of 6.0% from 2026 to 2031, culminating in a forecasted valuation of USD 9.33 billion by the end of the period. Growth momentum across Europe is fueled by the integration of advanced wound care technologies into European healthcare infrastructure, an emphasis on early diagnosis, and the development of wound care products for chronic and acute wounds. Additionally, investments in European healthcare infrastructure, a focus on quality, and collaboration between public healthcare centers and manufacturers are also fueling growth in this market.
KEY TAKEAWAYS
-
By Country
By country, the Rest of Europe held the largest share of the wound care market in Europe in 2025.
-
By Product
By product, the advanced wound care segment is expected to register the highest CAGR of 7.2% during the forecast period.
-
By Wound Type
By wound type, the chronic wound segment is expected to dominate the market in 2025 with the share of 57.9%.
-
By End User
By end user, the hospitals & clinics segment is expected to dominate the market in 2025 with the share of 56.5%.
-
Competitive Landscape
Molnlycke, Solventum and Smith+Nephew were identified as the star players in the Europe wound care market, supported by their strong market presence and extensive product portfolios.
-
Competitive Landscape
Advancis and Haromed bv have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas.
The wound care market in Europe is expected to increase during the forecast period because of growing incidences of injuries such as burns and trauma, as well as increased instances of chronic diseases observed in older generations. However, the high costs of advanced wound care products may restrain adoption. The market's growth is also constrained by a shortage of healthcare professionals. Additionally, in some underdeveloped areas, growth is limited by a lack of awareness.
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS
The Europe wound care market is closely tied to customer demand and treatment trends. The primary customers for wound care product manufacturers are hospitals, clinics, and healthcare centers. Changes in treatment patterns, acceptance of the latest therapies, and shifts in service delivery can significantly affect the demand for services provided by healthcare centers, which is the top-line business for wound care product manufacturers.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
MARKET DYNAMICS
Drivers
Impact
Level
-
Growing geriatric population
-
Rise in cases of traumatic injuries
RESTRAINTS
Impact
Level
-
High cost of advanced wound care products
-
Risks associated with use of advanced wound care products
OPPORTUNITIES
Impact
Level
-
Home-care Optimized Solutions
-
Technological advancement in wound care
CHALLENGES
Impact
Level
-
Lack of trained healthcare professionals
-
Data security and privacy concerns
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The Europe wound care market is fueled by the rise in trauma injuries, especially due to road and industrial accidents. The World Health Organization estimates about 1.3 million deaths and approximately 20-50 million non-fatal injuries annually due to traffic incidents. The majority of these deaths involve motorcycle and pedestrian riders. The International Labor Organization estimates around 270 million workplace injuries annually. These injuries often include serious wounds that, if not treated properly, may lead to complications such as infection and further damage.
Despite the proven effectiveness of advanced wound care products, their price makes them unaffordable to the general population. The higher price tag for other options, including bioengineered skin substitutes, antimicrobial dressings, and negative pressure therapy systems, would impose a substantial financial strain not only on patients but also on the entire health system. Of this amount, one would point out that the consequent foot lesions, particularly those related to diabetes mellitus, would rank among the fundamental reasons for the already mentioned hospitalization and would affect approximately 25% of the patients already identified as suffering from the chronic nature.
Integration of technology within the scope of wound management is increasingly recognized as one of the best opportunities in the wound care market. Smart technology and dressings with advanced capabilities are showing improved patient outcomes and supporting efficient, effective patient care. Advances in extended-wear negative-pressure wound therapy systems are making treatment easier and more adaptable for patients, even in primary care settings and beyond hospitals. The technology will help recognize treatment outcomes and reduce strain on healthcare infrastructure. In response to rising demands for faster healing with fewer complications, industry participants are likely to focus their growing expenditures on research and development to provide scalable, affordable solutions suitable for a significant population.
One of the most common barriers during the adoption process of wound care solutions is the lack of well-equipped medical professionals in most regions. It has been noted that not only is appropriate equipment required for proper wound management, which is why many are turning toward advanced wound care solutions, but the level of expertise during the application process is also required. In most cases, this lack of expertise results in delayed treatments, inappropriate diagnoses, and inappropriate use of advanced solutions by general medical practitioners and nurses who are not well equipped with the practices related to wound management. The lack of expertise not only results in difficulty managing cases related to foot ulcers and pressure sores found in diabetic patients, which require highly specialized application to achieve success, but also in the growth of the wound care market, driven by the challenges experienced by nations during the adoption process of highly advanced solutions due to the lack of well-equipped medical professionals to make their use possible in processes related to the health sector.
EUROPE WOUND CARE MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
|
|
Offers premium portfolio of advanced wound care including foam dressing, Negative Pressure Wound Therapy Solution and debridement solutions for complex wounds, burns, pressure ulcers and diabetic foot ulcers. | Decreases dressing change frequency, complications, comfort, and associated costs, resulting in quicker healing and superior clinical performance. |
|
|
Concentrates on innovative wound management with soft silicones based on Safetac Technology, high exudate foam absorbers, and pressure ulcer protection solutions for surgical areas, chronic wounds and vulnerable skin. | Facilitates dressing with reduced pain and trauma, promotes fast wound closure, and preserves injured skin, providing scientifically proven outcomes in the reduction of wound size, improvement in quality of life, and value-based care. |
|
|
Provides a comprehensive wound care product line that includes innovative solutions in advanced dressings, infection, skin protection, and compression. Provides care for both chronic and acute wounds. | Enhances healing outcomes by promoting effective control of exudates skin around the peri-wound site, and infection risk, thus aiding in optimizing treatment by standardizing practices and ensuring efficient treatment. |
|
|
Provides advanced solutions for wound care in the form of antimicrobial dressings, exuderate management dressings and NPWT solutions for treating chronic wounds, surgical wounds and difficult-to-heal ulcers. | Improves wound healing by regulating infection, moisture content and granulation tissue generation, thus reducing recovery time, hospital stay and total costs of treatment. |
|
|
Offers advanced solutions for wound care such as modern dressing products for moisturizing and protecting wounds, along with supportive products for the challenging management of wounds. | Facilitates more reliable wound progress by fostering a favorable healing environment and facilitating the reduction of drainage and dressing changes, patient discomfort, and preventable complications and overall cost of care. |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET ECOSYSTEM
The ecosystem market map for the Europe wound care market represents an interlinked structure in which manufacturers, distributors, healthcare organizations, partnering organizations for development, and other end users collaborate to manage wounds effectively and optimize patient care. The contribution of a manufacturer is evident when innovation drives enhancements through the development of sophisticated wound care products. Distributors, logistics providers, and group purchasing organizations also play a role by ensuring the timely delivery of products to support market access. End users include hospitals, ambulatory surgical centers, and home healthcare settings that adopt wound care solutions to facilitate quicker recovery, prevent infections, or enhance patient comfort.
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET SEGMENTS
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
In terms of products, the Europe wound care market includes advanced wound care products, surgical wound care products, and traditional wound care products. In 2025, advanced wound care products account for the largest share of the market. The market is segmented into advanced wound dressings by type, advanced wound dressings by property, wound therapy devices, biological skin substitutes, and topical agents. Patients have become more educated about how to care for their wounds. Moreover, hospital-acquired infections have increased, making advanced wound care products essential for effectively controlling these infections. Additionally, the market for advanced wound care products is being driven by the rising incidence of chronic wounds, such as diabetic foot ulcers, venous leg ulcers, and pressure ulcers. These wounds require prolonged treatment, and advanced wound care products help effectively heal them.
The Europe wound care market is categorized by wound type, consisting of chronic and acute wounds. As of 2025, this segment is dominated by chronic wounds. The chronic wound type is further categorized into diabetic foot ulcers, pressure ulcers, venous leg ulcers, among others. Growth in this market is largely driven by the rising number of chronic wounds worldwide. With this, the growing patient population is accompanied by a rising need for effective wound care products. Additionally, the increasing number of older adults has led to a greater need for wound care solutions that promote faster healing while reducing the likelihood of complications.
The Europe wound care market classification by end user includes wound care hospitals and clinics, home care settings, long-term care facilities, and other end users. In 2025, hospitals and clinics, comprising inpatient and outpatient centers, were estimated to lead the wound care market in terms of size. The primary reason is that more people are likely to visit these facilities for treatments of chronic wounds, such as pressure ulcers, foot ulcers in people with diabetes, and venous leg ulcers. These centers have qualified personnel and advanced medical equipment.
REGION
Germany is the fastest growing segment by country.
The German wound care market is anticipated to grow the fastest in Europe. This growth is driven by the rising adoption of advanced wound care products in both inpatient and outpatient facilities. Rising healthcare spending, favorable reimbursements, and growing awareness of the rising incidence of diabetes, along with a corresponding increase in diabetic foot ulcers and pressure sores, are among the factors supporting market growth in this country.
EUROPE WOUND CARE MARKET: COMPANY EVALUATION MATRIX
Smith+Nephew in Europe is the leading player in the wound care market, driven by its strong advanced wound management portfolio and long-standing presence across European healthcare systems. The company offers a wide range of wound care solutions, including advanced dressings, negative pressure wound therapy (NPWT), debridement, and wound closure support for chronic wounds, surgical wounds, burns, and hard-to-heal ulcers. These solutions are supported by clinically driven product design and integrated care pathways. Smith+Nephew's close alignment with clinical needs, focus on evidence-based innovation, patient comfort, and standardized wound care practices have enabled widespread adoption of its wound care solutions across hospitals and ambulatory settings, as well as in home healthcare.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
MARKET SCOPE
| REPORT METRIC | DETAILS |
|---|---|
| Market Size in 2025 (Value) | USD 6.62 Billion |
| Market Forecast in 2031 (Value) | USD 9.33 Billion |
| Growth Rate | CAGR of 6.0% from 2026-2031 |
| Years Considered | 2024-2031 |
| Base Year | 2024 |
| Forecast Period | 2026-2031 |
| Units Considered | Value (USD Million/Billion) |
| Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments Covered |
|
| Parent & Related Segment Reports |
Wound Care Market Asia Pacific Wound Care Market US Wound Care Market |
WHAT IS IN IT FOR YOU: EUROPE WOUND CARE MARKET REPORT CONTENT GUIDE
DELIVERED CUSTOMIZATIONS
We have successfully delivered the following deep-dive customizations:
| CLIENT REQUEST | CUSTOMIZATION DELIVERED | VALUE ADDS |
|---|---|---|
| Product Analysis | Product matrix, which provides a detailed comparison of the product portfolio of each company in the Europe wound care market | Enables easy comparison of competitors’ offerings, helping identify gaps, overlaps, and differentiation opportunities. |
| Company Information | Additional five company profiles of players operating in the Europe wound care market | Provides insights into competitors’ strategies, innovation focus in Europe, and partnerships, supporting strategic planning. |
RECENT DEVELOPMENTS
- March 2025: Convatec Group PLC (UK) and the Wound, Ostomy and Continence Nurses Society (US) collaborated to launch two free educational programs to improve ostomy care knowledge for healthcare professionals.
- October 2024: Mölnlycke AB (Sweden) acquired P.G.F. Industry Solutions, the manufacturer of Granudacyn wound cleansing and moistening solutions. The acquisition strengthened Mölnlycke’s wound care portfolio and expanded the distribution network of Granudacyn which is available in over 50 countries.
- July 2023: Coloplast Group (Denmark)signed an agreement to acquire Kerecis enhancing its position in the biologics wound care segment and raising long-term growth expectations.
- April 2024: Smith+Nephew (UK) introduced the RENASYS EDGE System is designed for home care patients with chronic wounds, such as ulcers.
Table of Contents
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
TITLE
PAGE NO
1
INTRODUCTION
15
2
EXECUTIVE SUMMARY
3
PREMIUM INSIGHTS
4
MARKET OVERVIEW
4.1
INTRODUCTION
4.2
MARKET DYNAMICS
4.3
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.4
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5
INDUSTRY TRENDS
5.1
PORTER'S FIVE FORCES ANALYSIS
5.2
MACROECONOMICS OUTLOOK
5.2.1
INTRODUCTION
5.2.2
GDP TRENDS AND FORECAST
5.2.3
TRENDS IN EUROPE WOUND CARE MARKET
5.3
VALUE CHAIN ANALYSIS
5.4
ECOSYSTEM ANALYSIS
5.5
PRICING ANALYSIS
5.5.1
AVERAGE SELLING PRICE TREND OF WOUND CARE PRODUCTS, BY KEY PLAYER, 2024-2026
5.5.2
AVERAGE SELLING PRICE TREND OF WOUND CARE PRODUCTS, BY TYPE, 2024-2026
5.6
TRADE ANALYSIS
5.6.1
IMPORT SCENARIO
5.9
EXPORT SCENARIO
5.7
KEY CONFERENCES AND EVENTS (2026-2027)
5.8
TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
5.9
INVESTMENT AND FUNDING SCENARIO
5.10
IMPACT OF 2025 US TARIFF ON EUROPE WOUND CARE MARKET
5.10.1
INTRODUCTION
5.10.2
KEY TARIFF RATES
5.10.3
PRICE IMPACT ANALYSIS
5.10.4
IMPACT ON END-USE INDUSTRIES
6
STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTION
6.1
KEY EMERGING TECHNOLOGIES
6.2
COMPLEMENTARY TECHNOLOGIES
6.3
TECHNOLOGY/PRODUCT ROADMAP
6.4
PATENT ANALYSIS
6.5
IMPACT OF AI/GEN AI ON EUROPE WOUND CARE MARKET
6.5.1
TOP USE CASES AND MARKET POTENTIAL
6.5.2
CASE STUDIES OF AI IMPLEMENTATION
6.5.3
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
6.5.4
CLIENTS’ READINESS TO ADOPT GENERATIVE AI
7
REGULATORY LANDSCAPE
7.1
REGIONAL REGULATIONS AND COMPLIANCE
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.1.2
INDUSTRY STANDARDS
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.1
DECISION-MAKING PROCESS
8.2
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
9
EUROPE WOUND CARES MARKET, BY PRODUCT (MARKET SIZE & FORECAST TO 2031 – USD MILLION)
9.1
INTRODUCTION
9.2
ADVANCED WOUND CARE PRODUCTS
9.2.1
ADVANCED WOUND DRESSINGS, BY TYPE
9.2.1.1
FOAM DRESSINGS
9.2.1.1.1
SILICON FOAM DRESSINGS
9.2.1.1.2
NON SILICON FOAM DRESSINGS
9.2.1.2
HYDROCOLLOID DRESSINGS
9.2.1.3
FILM DRESSINGS
9.2.1.4
ALGINATE DRESSINGS
9.2.1.5
HYDROGEL DRESSINGS
9.2.1.6
COLLAGEN DRESSINGS
9.2.1.7
HYDROFIBER DRESSINGS
9.2.1.8
WOUND CONTACT LAYERS
9.2.1.9
SUPERABSORBENT DRESSINGS
9.2.1.10
OTHER ADVANCED WOUND CARE DRESSINGS
9.2.2
ADVANCED WOUND DRESSINGS, BY PROPERTIES
9.2.2.1
NON-ANTIMICROBIAL DRESSINGS
9.2.2.2
ANTIMICROBIAL DRESSINGS
9.2.3
DEVICES & ACCESSORIES
9.2.3.1
NPWT DEVICES & ACCESSORIES
9.2.3.2
DEBRIDEMENT DEVICES & ACCESSORIES
9.2.3.3
WOUND ASSESSMENT & MONITORING DEVICES
9.2.3.4
OTHER DEVICES & ACCESSORIES
9.2.4
BIOLOGICAL SKIN SUBSTITUTES
9.2.4.1
HUMAN DONOR TISSUE-DERIVED PRODUCTS
9.2.4.2
ACELLULAR ANIMAL-DERIVED PRODUCTS
9.2.4.3
BIOSYNTHETIC PRODUCTS
9.2.5
TOPICAL AGENTS
9
.3 SURGICAL WOUND CARE PRODUCTS
9.3.1
SUTURES
9.3.2
TISSUE ADHESIVES, SEALANTS, AND GLUES
9.3.2.1
FIBRIN-BASED SEALANTS
9.3.2.2
SYNTHETIC ADHESIVES
9.3.2.3
COLLAGEN-BASED SEALANTS
9.3.3
STAPLERS
9.4
TRADITIONAL WOUND CARE PRODUCTS
9.4.1
FIXATIONS
9.4.2
BANDAGES
9.4.3
GAUZES
9.4.4
FIRST AID PLASTERS
9.4.5
ABSORBENT PADS
9.4.6
COMPRESSIONS
9.4.7
DRESSINGS
9.4.8
OTHER TRADITIONAL WOUND CARE PRODUCTS
10
EUROPE WOUND CARES MARKET, BY WOUND TYPE (MARKET SIZE & FORECAST TO 2031 – USD MILLION)
10.1
INTRODUCTION
10.2
CHRONIC WOUNDS
10.2.1
DIABETIC FOOT ULCERS
10.2.2
PRESSURE ULCERS
10.2.3
VENOUS LEG ULCERS
10.2.4
OTHER CHRONIC WOUNDS
10.3
ACUTE WOUNDS
10.3.1
SURGICAL & TRAUMATIC WOUNDS
10.3.2
BURNS
11
EUROPE WOUND CARES MARKET, BY END USER (MARKET SIZE & FORECAST TO 2031 – USD MILLION)
11.1
INTRODUCTION
11.2
HOSPITALS & CLINICS
11.2.1
DIABETIC FOOT ULCERS
11.2.2
PRESSURE ULCERS
11.3
HOME CARE SETTINGS
11.4
LONG-TERM CARE FACILITIES
11.5
OTHER END USERS
12
EUROPE WOUND CARE MARKET, BY COUNTRY (MARKET SIZE & FORECAST TO 2031 – USD MILLION)
12.1
INTRODUCTION
12.2
GERMANY
12.3
FRANCE
12.4
UK
12.5
ITALY
12.6
SPAIN
12.7
RUSSIA
12.8
REST OF EUROPE
13
EUROPE WOUND CARE MARKET, COMPETITIVE LANDSCAPE
13.1
INTRODUCTION
13.2
KEY PLAYER STRATEGIES/RIGHT-TO-WIN
13.3
REVENUE ANALYSIS, 2021–2025
13.4
MARKET SHARE ANALYSIS,
13.5
COMPANY VALUATION & FINANCIAL METRICS
13.6
BRAND COMPARISON
13.7
COMPANY EVALUATION MATRIX: KEY PLAYERS,
13.7.1
STARS
13.7.2
EMERGING LEADERS
13.7.3
PERVASIVE PLAYERS
13.7.4
PARTICIPANTS
13.7.5
COMPANY FOOTPRINT: KEY PLAYERS,
13.7.5.1
COMPANY FOOTPRINT
13.7.5.2
PRODUCT FOOTPRINT
13.7.5.3
WOUND TYPE FOOTPRINT
13.7.5.4
END USER FOOTPRINT
13.8
COMPANY EVALUATION MATRIX: STARTUPS/SMES,
13.8.1
PROGRESSIVE COMPANIES
13.8.2
RESPONSIVE COMPANIES
13.8.3
DYNAMIC COMPANIES
13.8.4
STARTING BLOCKS
13.8.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES,
13.8.5.1
DETAILED LIST OF KEY STARTUPS/SMES
13.8.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
13.9
COMPETITIVE SITUATION AND TRENDS
14
EUROPE WOUND CARE MARKET, COMPANY PROFILES
14.1
KEY PLAYERS
14.1.1
SOLVENTUM
14.1.2
JOHNSON & JOHNSON SERVICES, INC. (ETHICON)
14.1.3
SMITH +NEPHEW
14.1.4
CARDINAL HEALTH
14.1.5
MÖLNLYCKE AB
14.1.6
CONVATEC GROUP PLC
14.1.7
COLOPLAST GROUP
14.1.8
ORGANOGENESIS INC.
14.1.9
PAUL HARTMANN AG
14.1.10
MIMEDEX GROUP, INC
14.1.11
OWENS & MINOR
14.1.12
B.BRAUN SE
14.1.13
ESSITY AKTIEBOLAG
14.1.14
INTEGRA LIFESCIENCES CORPORATION
14.1.15
AVERY DENNISON CORPORATION
14.1.16
MATIV HOLDINGS, INC.
14.1.17
BIOVENTUS
14.1.18
ZIMMER BIOMET
14.1.19
MEDTRONIC
14.1.20
BAXTER
14.2
OTHER PLAYERS
14.2.1
LOHMANN & RAUSHER GMBH & CO.KG
14.2.2
MEDLINE INDUSTRIES
14.2.3
WINNER MEDICAL CO., LTD.
14.2.4
URGO GROUP
14.2.5
DIRECT HEALTHCARE GROUP
14.2.6
ADVANCIS
15
RESEARCH METHODOLOGY
15.1
RESEARCH DATA
15.1.1
SECONDARY DATA
15.1.1.1
KEY DATA FROM SECONDARY SOURCES
15.1.2
PRIMARY DATA
15.1.3
MARKET SIZE ESTIMATION
15.1.3.1
BOTTOM-UP APPROACH
15.1.3.2
TOP-DOWN APPROACH
15.1.3.3
BASE NUMBER CALCULATION
15.1.4
MARKET FORECAST APPROACH
15.1.4.1
SUPPLY SIDE
15.1.4.2
DEMAND SIDE
15.1.5
DATA TRIANGULATION
15.1.6
FACTOR ANALYSIS
15.1.7
RESEARCH ASSUMPTIONS
15.1.8
RESEARCH LIMITATIONS AND RISK ASSESSMENT
16
APPENDIX
16.1
DISCUSSION GUIDE
16.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
16.3
CUSTOMIZATION OPTIONS
16.4
RELATED REPORTS
16.5
AUTHOR DETAILS
Methodology
The study involved major activities in estimating the current market size for the Europe Wound Care Market . Exhaustive secondary research was done to collect information on the wound care industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the Europe Wound Care Market.
Secondary Research
The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, investor presentations, SEC filings of companies and publications from government sources [such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), , Global Burden of Disease Study, and Centers for Medicare and Medicaid Services (CMS) were referred to identify and collect information for the Europe Wound Care Market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the Europe Wound Care Market . The primary sources from the demand side include pharmaceutical companies, biotechnology companies, CROs, pharmacies, medical device companies, and research academics and universities. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.
Market Size Estimation
For the market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the Europe Wound Care Market . All the major service providers were identified at the country/regional level. Revenue mapping for the respective business segments/sub-segments was done for the major players. The Europe Wound Care Market was split into various segments and sub-segments based on:
- List of major players operating in the product market at the regional and/or country level
- Product mapping of wound care providers at the country level
- Mapping of annual revenue generated by listed major players from wound care (or the nearest reported business unit/product category)
- Extrapolation of the revenue mapping of the listed major players to derive the market value of the respective segments/subsegments
- Summation of the market value of all segments/subsegments to arrive at the Europe Wound Care Market
The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.
The research methodology used to estimate the market size includes the following:
Data Triangulation
After arriving at the overall market size by applying the process mentioned above, the total market was split into several segments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Wound care involves using various products, such as dressings, devices, and biologics, to facilitate the rapid healing and management of wounds. Wound care enables an individual’s injuries to transition into smoother, cost-effective, and treatment-efficient healing.
Stakeholders
- Wound Care Product Manufacturers
- Wound Care Associates
- Research and Consulting Firms
- Distributors of Wound Care Devices
- Contract Manufacturers of Wound Care Products
- Healthcare Institutes (Hospitals, Medical Schools, Diagnostic Centers, and Outpatient Clinics)
- Research Institutes
- Venture Capitalists
Report Objectives
- To define, describe, segment, and forecast the Europe Wound Care Market by product, wound type, end user, and region
- To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall Europe Wound Care Market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To benchmark players within the market using the proprietary Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business and product excellence
- To study the impact of AI/Gen AI on the market, along with the macroeconomic outlook for each region
⚡ Growth Signals
Personalize This Research
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
Let Us Help You
- What are the Known and Unknown Adjacencies Impacting the Europe Wound Care Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
JAYANT RAJPUROHIT
Director of Market Insights, Data and Analytics
SFI Health,
Leading Pharmaceutical Company
We at SFI Health approached MarketsandMarkets for an Opportunity Assessment on "Incidence and Prevalence of Focus Indications" as we wanted to know the most attractive HCPs like Physician, Functional MD, Naturopath and Pharmacist. The project was critical for us to ensure our focus on the right target which would enable sustainable growth and profitability for SFI Health. The business insights provided exceeded our expectations and we were extremely impressed. The team at MarketsandMarkets is highly professional and detail oriented and very well understood our business needs. MarketsandMarkets offers a unique combination of expertise and dedicated engagement model. We identified 2 new products to be launched in coming months, based on the research findings provided by MarketsandMarkets. We are happy with the services and would strongly recommend MarketsandMarkets to my peers in the industry.
BEATRIZ DE LA CALLE
Head of Commercial Analytics
Qualicaps,
Leading Pharmaceutical Company
We partnered with MarketsandMarkets for an assessment study on hard empty capsules. The team was extremely professional in understanding our business requirements and we received timely responses to all our queries. The market intelligence and the recommendations has met our business requirements. We were extremely impressed to see the final study results; it really exceeded our expectations. The market intelligence offered by MarketsandMarkets, and clarity on next steps will help us achieve our business objective for the Year 2021. We are happy with the services and would strongly recommend MarketsandMarkets to my peers in the industry.
Bob Williams,
Senior Director Business Development & Innovation
Bracco Diagnostics Inc.,
Italian Multinational in life sciences sector and a World Leader in imaging diagnostics
We were pleased with targeted insights that MarketsandMarkets identified from a custom study on the 'Radiation Dose Management Solutions Market'. Your team identified and characterized the market participants as well as underlying trends accurately. This study was useful to Bracco in formulating business strategies for our dose monitoring product lines and we thank MarketsandMarkets for the job well done.
Cody Coonradt,
Market Development and Strategy Manager
3M Health Information Systems,
Leader in Health care Coding, Payment & Analytics Solutions.
The value for our organization comes from three things: depth of research, specificity of segments and being easy to work with. As important as the first two are, the third can't be underestimated. MarketsandMarkets, maybe more than any other research vendor, wants to know what is top of mind for our team and what big questions we are grappling to answer.
Their customer first approach and high value engagement model, have given us great analysis and excellent value for money
Still Researching the
Europe Wound Care Ecosystem?
See the competitors, opportunities, and growth signals shaping it - instantly.
Generate 15+ consulting-grade strategic insights tailored to your growth question.
Explore Europe Wound Care Intelligence
Powered by 17 years of MarketsandMarkets intelligence
